Logo

PharmaShots Weekly Snapshots (Feb 22- 26, 2021)

Share this

PharmaShots Weekly Snapshots (Feb 22- 26, 2021)

Regeneron Reports IDMC Clearance of Efficacy for REGEN-COV (Casirivimab + Imdevimab) in P-III COVID-19 Outpatient Outcomes Trial

Published: Feb 26, 2021 | Tags: Regeneron, Reports, IDMC, Clearance, Efficacy, REGEN-COV (Casirivimab + Imdevimab), P-III, COVID-19, Outpatient, Outcomes, Trial

Daiichi Sankyo Collaborates with LYSA-LYSARC-CALYM for Valemetostat in Patients with R/R B-Cell Lymphoma

Published: Feb 26, 2021 | Tags: Daiichi Sankyo, Collaborates, LYSA-LYSARC-CALYM, Valemetostat,  Patients, R/R B-Cell Lymphoma

Lilly to Integrate its Digital Insulin Pen with Welldoc's BlueStar App

Published: Feb 26, 2021 | Tags: Lilly, Integrate, Digital Insulin Pen, Welldoc, BlueStar App

GSK Report Results of Otilimab in P-II OSCAR Study to Treat Hospitalized Patients with COVID-19

Published: Feb 26, 2021 | Tags: GSK, Report, Results, Otilimab, P-II, OSCAR Study, Treat, Hospitalized Patients, COVID-19

Otsuka and Click Initiate Digital Study in Adults with Major Depressive Disorder

Published: Feb 26, 2021 | Tags: Otsuka and Click, Initiate, Digital, Study, Adults, Major, Depressive Disorder

Merck to Acquire Pandion for ~$1.85B

Published: Feb 26, 2021 | Tags: Merck, Acquire, Pandion, ~$1.85B

Intra-Cellular Reports the Expansion of Pipeline with the Addition of ITI-1284

Published: Feb 25, 2021 | Tags: Intra-Cellular, Reports, Expansion, Pipeline, Addition, ITI-1284

Qiagen Expand its Collaboration with Inovio to Develop Liquid Biopsy Based CDx for VGX-3100 to Treat Advanced Cervical Dysplasia

Published: Feb 25, 2021 | Tags: Qiagen, Expand, Collaboration, Inovio, Develop, Liquid Biopsy, Based CDx, VGX-3100, Treat, Advanced, Cervical Dysplasia

AbbVie's Humira (adalimumab) Receives the US FDA's Approval to Treat Pediatric Patients with Ulcerative Colitis

Published: Feb 25, 2021 | Tags: AbbVie, Humira (adalimumab), Receives, US, FDA, Approval, Treat, Pediatric, Patients, Ulcerative Colitis

Roche Report Results of Evrysdi (risdiplam) in FIREFISH Study for Infants with Type 1 SMA

Published: Feb 25, 2021 | Tags: Roche, Report, Results, Evrysdi (risdiplam), FIREFISH, Study, Infant, Type 1 SMA

Sanofi Collaborates with Sirion to Develop Gene Therapy Treatment with Improved AAV Capsids

Published: Feb 25, 2021 | Tags: Sanofi, Collaborates, Sirion, Develop, Gene Therapy, Treatment,  Improved, AAV Capsids

UCB Collaborates with Microsoft to Accelerate Drug Discovery and Development

Published: Feb 25, 2021 | Tags: UCB, Collaborates, Microsoft, Accelerate, Drug, Discovery, Development

Bio-Techne Collaborates with Luminary to Utilize TcBuster in the Development of CAR-T cell Therapies

Published: Feb 24, 2021 | Tags: Bio-Techne, Collaborates, Luminary, Utilize, TcBuster, Development, CAR-T cell, Therapies

Takeda Reports First Patients Dosing in P-I/II Study of Novavax's COVID-19 Vaccine Candidate in Japan

Published: Feb 24, 2021 | Tags: Takeda, Reports, First, Patients, Dosing, P-I/II, Study, Novavax, COVID-19, Vaccine Candidate, Japan

Pfizer Reports the US FDA's Acceptance and Priority Review of BLA for Ticovac (Tick-Borne Encephalitis Vaccine)

Published: Feb 24, 2021 | Tags: Pfizer, Reports, US, FDA, Acceptance, Priority Review, BLA, Ticovac (Tick-Borne Encephalitis Vaccine)

Merck KGaA Signs an Exclusive Worldwide License Agreement with Day One for Pimasertib and MSC2015103B

Published: Feb 24, 2021 | Tags: Merck, KGaA, Signs, Exclusive, Worldwide, License, Agreement, Day One, Pimasertib, MSC2015103B

Sanofi's Dupixent (dupilumab) Receives Health Canada Approval as the First Biologic to Treat Atopic Dermatitis in Children

Published: Feb 24, 2021 | Tags: Sanofi, Dupixent (dupilumab), Receives, Health Canada, Approval, First, Biologic, Treat, Atopic Dermatitis, Children

Graviton Signs an Exclusive Worldwide License Agreement with Beijing Tide for TDI01

Published: Feb 24, 2021 | Tags: Graviton, Signs, Exclusive, Worldwide, License, Agreement, Beijing Tide, TDI01

MatriSys Report Results of MSB-0221 in P-I study for the Topical Treatment of Atopic Dermatitis

Published: Feb 23, 2021 | Tags: MatriSys, Report, Results, MSB-0221, P-I study, Topical, Treatment, Atopic Dermatitis

Amgen Reports sNDA Submission of Otezla (apremilast) to The US FDA's for Adults with Mild to Moderate Plaque Psoriasis

Published: Feb 23, 2021 | Tags: Amgen, Reports, sNDA, Submission, Otezla (apremilast), US, FDA, Adults, Mild, Moderate, Plaque Psoriasis

BMS Expands its Collaboration with Compugen to Evaluate the Combination of COM701 + Opdivo

Published: Feb 23, 2021 | Tags: BMS, Expands, Collaboration, Compugen, Evaluate, Combination,  COM701 + Opdivo

Incyte Reports the US FDA's Acceptance of sNDA for Priority Review of Jakafi (ruxolitinib) to Treat Chronic Graft Versus Host Disease

Published: Feb 23, 2021 | Tags: Incyte, Reports, US, FDA, Acceptance, sNDA, Priority Review, Jakafi (ruxolitinib), Treat, Chronic, Graft, Versus, Host Disease

AbbVie Report Results of Rinvoq (upadacitinib) in Second P-III Induction Study for Ulcerative Colitis

Published: Feb 23, 2021 | Tags: AbbVie, Report, Results, Rinvoq (upadacitinib), Second, P-III, Induction Study, Ulcerative Colitis

Regeneron and Sanofi's Libtayo (cemiplimab-rwlc) Receive the US FDA's Approval as 1L Treatment for Advanced NSCLC

Published: Feb 23, 2021 | Tags: Regeneron and Sanofi, Libtayo (cemiplimab-rwlc), Receive, US, FDA, Approval, 1L, Treatment, Advanced, NSCLC

Sanofi and GSK Initiate P-II Study of their Adjuvanted Recombinant Protein-Based COVID-19 Vaccine

Published: Feb 22, 2021 | Tags: Sanofi and GSK, Initiate, P-II, Study, Adjuvanted, Recombinant Protein-Based, COVID-19, Vaccine

AstraZeneca to Withdraw Imfinzi Indication in Advanced Bladder Cancer in the US

Published: Feb 22, 2021 | Tags: AstraZeneca, Withdraw, Imfinzi, Indication, Advanced, Bladder Cancer, US

Incyte Reports the US FDA's Acceptance of NDA for Priority Review of Ruxolitinib Cream to Treat Atopic Dermatitis

Published: Feb 22, 2021 | Tags: Incyte, Reports, US, FDA, Acceptance, NDA, Priority Review, Ruxolitinib Cream, Treat, Atopic Dermatitis

Astellas Reports Results of Fezolinetant in Two P-III Studies for the Nonhormonal Treatment of VMS in Postmenopausal Women

Published: Feb 22, 2021 | Tags: Astellas, Reports, Results, Fezolinetant, Two, P-III, Studies, Nonhormonal, Treatment, VMS, Postmenopausal, Women

Immunocore's Tebentafusp Receives the US FDA's Breakthrough Therapy Designation for Unresectable or Metastatic Uveal Melanoma

Published: Feb 22, 2021 | Tags: Immunocore, Tebentafusp, Receives, US, FDA Breakthrough, Therapy, Designation, Unresectable, Metastatic, Uveal Melanoma

Roche Concludes the License Agreement with Chugai for AT-527 to Treat COVID-19 in Japan

Published: Feb 22, 2021 | Tags: Roche, Concludes, License, Agreement, Chugai, AT-527, Treat, COVID-19, Japan

Related post: PharmaShots Weekly Snapshots (Feb 15- 19, 2021)


Senior Editor

This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions